Diabetic retinopathy (DR) is a leading cause of visual impairment and blindness worldwide.
Since DR was first recognized as an important complication of diabetes, there have been …

Diabetic retinopathy (DR), one of the leading causes of preventable blindness, has been
considered a microcirculatory disease of the retina. However, there is emerging evidence to …

Diabetic retinopathy (DR) is one of the leading causes of visual impairment in the working-
age population. DR is a progressive eye disease caused by long-term accumulation of …

Diabetic retinopathy (DR), commonly classified as a microvascular complication of diabetes,
is now recognized as a neurovascular complication or sensory neuropathy resulting from …

Somatostatin is an endogeneous cyclic tetradecapeptide hormone that exerts multiple
biological activities via five ubiquitously distributed receptor subtypes. Classified as a broad …

Purpose To review the evidence supporting diabetic retinal neurodegeneration (DRN) as a
form of diabetic retinopathy. Method Review of literature. Results DRN is recognized to be a …

Diabetic retinopathy (DR) has been classically considered to be a microcirculatory disease
of the retina caused by the deleterious metabolic effects of hyperglycemia per se and the …

Diabetic retinopathy (DR) remains the leading cause of blindness among working-age
individuals in developed countries. Current treatments for DR are indicated in advanced …

Retinal neurodegeneration is an early event in the pathogenesis of diabetic retinopathy
(DR). Somatostatin (SST) is an endogenous neuroprotective peptide that is downregulated …

Oxygen-derived free radicals such as hydroxyl and hydroperoxyl species have been shown
to oxidize phospholipids and other membrane lipid components leading to lipid …